INPP5D and B-cell chronic lymphocytic leukemia: While B cells derived from the peripheral blood of healthy donors and Bal17, BJAB and SUDHL6 lymphoma cells remained largely unaffected in terms of viability upon 3AC treatment (Fig. 2f), SHIP1 inhibition-induced cell death specifically in CLL cells, including the MEC-1 and EHEB cell lines.